Published in BMJ on November 23, 2002
Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. BMJ (2011) 3.84
Psychiatric comorbidities and schizophrenia. Schizophr Bull (2008) 2.69
A controlled family study of cannabis users with and without psychosis. Schizophr Res (2013) 2.00
The environment and susceptibility to schizophrenia. Prog Neurobiol (2010) 1.94
Blurred boundaries: the therapeutics and politics of medical marijuana. Mayo Clin Proc (2012) 1.79
Adolescent cannabis problems and young adult depression: male-female stratified propensity score analyses. Am J Epidemiol (2008) 1.63
Cannabis use disorders in schizophrenia: effects on cognition and symptoms. Schizophr Res (2010) 1.55
The association between delusional-like experiences, and tobacco, alcohol or cannabis use: a nationwide population-based survey. BMC Psychiatry (2011) 1.54
Epidemiology of schizophrenia: review of findings and myths. Psychiatr Clin North Am (2007) 1.41
Cannabis and psychosis/schizophrenia: human studies. Eur Arch Psychiatry Clin Neurosci (2009) 1.37
Gene-environment interplay between cannabis and psychosis. Schizophr Bull (2008) 1.34
Sensitivity of ICD-10 diagnosis of psychotic disorders in the Israeli National Hospitalization Registry compared with RDC diagnoses based on SADS-L. Compr Psychiatry (2005) 1.34
Medical marijuana laws and suicides by gender and age. Am J Public Health (2014) 1.33
Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models. Br J Pharmacol (2010) 1.33
Cannabis abuse and risk for psychosis in a prodromal sample. Psychiatry Res (2007) 1.32
Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophr Bull (2009) 1.30
A social deafferentation hypothesis for induction of active schizophrenia. Schizophr Bull (2007) 1.26
Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia? J Psychiatry Neurosci (2007) 1.18
Substance abuse by children and young people. Arch Dis Child (2004) 1.16
Gone to Pot - A Review of the Association between Cannabis and Psychosis. Front Psychiatry (2014) 1.14
Genetic predisposition to schizophrenia associated with increased use of cannabis. Mol Psychiatry (2014) 1.13
Amphetamine-induced psychosis--a separate diagnostic entity or primary psychosis triggered in the vulnerable? BMC Psychiatry (2012) 1.12
Association between cannabis use, psychosis, and schizotypal personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Schizophr Res (2013) 1.10
Cannabis and mental health. BMJ (2002) 1.09
Cannabis use and the risk of developing a psychotic disorder. World Psychiatry (2008) 1.08
Childhood sexual abuse, early cannabis use, and psychosis: testing an interaction model based on the National Comorbidity Survey. Schizophr Bull (2007) 1.08
Cannabis and the general practitioner--'going to pot'. Br J Gen Pract (2003) 1.08
Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice. Neuropsychopharmacology (2011) 1.07
Substance use in clinical high risk for psychosis: a review of the literature. Early Interv Psychiatry (2013) 1.06
A classification of sociomedical health indicators: perspectives for health administrators and health planners. Int J Health Serv (1976) 1.04
Association between age at onset of psychosis and age at onset of cannabis use in non-affective psychosis. Schizophr Res (2012) 1.03
Impairments in cognition across the spectrum of psychiatric disorders: evidence from a Swedish conscript cohort. Schizophr Bull (2008) 1.02
CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity. J Psychopharmacol (2011) 1.02
Schizophrenia: from epidemiology to rehabilitation. Clin Pract Epidemiol Ment Health (2012) 1.02
Role of cannabis and endocannabinoids in the genesis of schizophrenia. Psychopharmacology (Berl) (2009) 1.01
Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia. Schizophr Res (2011) 1.01
Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence. Neuroscience (2011) 1.01
The impact of substance use on brain structure in people at high risk of developing schizophrenia. Schizophr Bull (2010) 1.00
Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome. Psychol Med (2012) 1.00
The role of cannabis in cognitive functioning of patients with schizophrenia. Psychopharmacology (Berl) (2009) 0.99
Cannabis and schizophrenia. Cochrane Database Syst Rev (2008) 0.99
The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia? Curr Opin Psychiatry (2008) 0.95
Pathways from cannabis to psychosis: a review of the evidence. Front Psychiatry (2013) 0.94
Harm reduction--the cannabis paradox. Harm Reduct J (2005) 0.94
Drug-induced psychosis: how to avoid star gazing in schizophrenia research by looking at more obvious sources of light. Front Behav Neurosci (2011) 0.94
Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage. Br J Pharmacol (2006) 0.92
Susceptibility of the adolescent brain to cannabinoids: long-term hippocampal effects and relevance to schizophrenia. Transl Psychiatry (2012) 0.92
Cannabis use and cognition in schizophrenia. Front Hum Neurosci (2009) 0.91
Associations of cannabis and cigarette use with psychotic experiences at age 18: findings from the Avon Longitudinal Study of Parents and Children. Psychol Med (2014) 0.91
Interpreting the association between cannabis use and increased risk for schizophrenia. Dialogues Clin Neurosci (2005) 0.90
Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis. Schizophr Bull (2016) 0.90
Early cannabis use and schizotypal personality disorder symptoms from adolescence to middle adulthood. Schizophr Res (2012) 0.88
Comorbid substance abuse and brain morphology in recent-onset psychosis. Eur Arch Psychiatry Clin Neurosci (2009) 0.87
Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed. Neuropsychopharmacology (2015) 0.87
Cannabinoid CB1 receptor-mediated impairment of visuospatial attention in the rat. Psychopharmacology (Berl) (2004) 0.86
Age at initiation of cannabis use predicts age at onset of psychosis: the 7- to 8-year trend. Schizophr Bull (2013) 0.86
Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia. Eur Arch Psychiatry Clin Neurosci (2006) 0.86
The association between cannabis abuse and subsequent schizophrenia: a Swedish national co-relative control study. Psychol Med (2014) 0.86
Association of Cannabis Use during Adolescence, Prefrontal CB1 Receptor Signaling, and Schizophrenia. Front Pharmacol (2012) 0.85
Impact of Cannabis Use on the Development of Psychotic Disorders. Curr Addict Rep (2014) 0.85
Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia. Schizophr Res (2010) 0.85
Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration. Mini Rev Med Chem (2009) 0.84
Environmental risk factors for psychosis. Dialogues Clin Neurosci (2005) 0.84
Cannabis use and depression: a longitudinal study of a national cohort of Swedish conscripts. BMC Psychiatry (2012) 0.84
Concurrent and Sustained Cumulative Effects of Adolescent Marijuana Use on Subclinical Psychotic Symptoms. Am J Psychiatry (2016) 0.84
Schizophrenia and neural tube defects: comparisons from an epidemiological perspective. Schizophr Bull (2006) 0.83
Elevated homocysteine level in first-episode schizophrenia patients--the relevance of family history of schizophrenia and lifetime diagnosis of cannabis abuse. Metab Brain Dis (2014) 0.83
Visual scan paths in first-episode schizophrenia and cannabis-induced psychosis. J Psychiatry Neurosci (2007) 0.83
GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia. Curr Neuropharmacol (2005) 0.83
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis. World Psychiatry (2016) 0.82
Cannabis, a complex plant: different compounds and different effects on individuals. Ther Adv Psychopharmacol (2012) 0.82
Endocannabinoid system: potential novel targets for treatment of schizophrenia. Neurobiol Dis (2012) 0.82
Endocannabinoid signaling in midbrain dopamine neurons: more than physiology? Curr Neuropharmacol (2007) 0.82
Cannabis and breastfeeding. J Toxicol (2009) 0.81
(AAT)n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish population. Eur Arch Psychiatry Clin Neurosci (2006) 0.81
The mental health risks of adolescent cannabis use. PLoS Med (2006) 0.81
Comparison of Cannabinoid CB(1) Receptor Binding in Adolescent and Adult Rats: A Positron Emission Tomography Study Using [F]MK-9470. Int J Mol Imaging (2011) 0.80
Prenatal stress and peripubertal stimulation of the endocannabinoid system differentially regulate emotional responses and brain metabolism in mice. PLoS One (2012) 0.80
Prognosis of schizophrenia in persons with and without a history of cannabis use. Psychol Med (2014) 0.79
Alcohol and Relatively Pure Cannabis Use, but Not Schizotypy, are Associated with Cognitive Attenuations. Front Psychiatry (2014) 0.79
Anandamide protects HT22 cells exposed to hydrogen peroxide by inhibiting CB1 receptor-mediated type 2 NADPH oxidase. Oxid Med Cell Longev (2014) 0.79
Permanent suppression of cortical oscillations in mice after adolescent exposure to cannabinoids: receptor mechanisms. Neuropharmacology (2014) 0.78
Cannabinoids for the treatment of schizophrenia? A balanced neurochemical framework for both adverse and therapeutic effects of cannabis use. Schizophr Res Treatment (2010) 0.78
Cannabis and psychopathology : update 2004. Indian J Psychiatry (2004) 0.78
A retrospective analysis of cannabis use in a cohort of mentally ill patients in Sri Lanka and its implications on policy development. Subst Abuse Treat Prev Policy (2010) 0.78
Marijuana use in the immediate 5-year premorbid period is associated with increased risk of onset of schizophrenia and related psychotic disorders. Schizophr Res (2016) 0.78
Hemispheric language asymmetry in first episode psychosis and schizotypy: the role of cannabis consumption and cognitive disorganization. Schizophr Bull (2014) 0.78
Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence. Front Pharmacol (2016) 0.78
Total exposure duration and proximity of cessation of cannabis use predict severity of sub-clinical psychotic symptoms among former users. Psychiatry Res (2012) 0.78
The treatment of schizophrenia: from premorbid manifestations to the first episode of psychosis. Dialogues Clin Neurosci (2005) 0.77
MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse. Psychol Med (2012) 0.77
The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability. Front Psychiatry (2014) 0.77
An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use. Front Psychiatry (2012) 0.77
Treated incidence and baseline characteristics of substance induced psychosis in a Norwegian catchment area. BMC Psychiatry (2013) 0.76
A retrospective analysis focusing on a group of patients with dual diagnosis treated by both mental health and substance use services. Neuropsychiatr Dis Treat (2014) 0.76
Cannabis and schizophrenia spectrum disorders: a review of clinical studies. Indian J Psychol Med (2009) 0.76
Association of abnormal semantic processing with delusion-like ideation in frequent cannabis users: an electrophysiological study. Psychopharmacology (Berl) (2012) 0.76
Destructive Effects of Prenatal WIN 55212-2 Exposure on Central Nervous System of Neonatal Rats. Addict Health (2014) 0.76
The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in Schizophrenia. Biol Psychiatry (2015) 0.76
Cannabis use by children and young people. Arch Dis Child (2006) 0.76
The natural history of drug use from adolescence to the mid-thirties in a general population sample. Am J Public Health (1995) 6.03
Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry (1991) 5.36
Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science (1997) 3.77
Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet (1987) 3.61
Schizophrenia and city life. Lancet (1992) 3.60
Premorbid adjustment and personality in people with schizophrenia. Br J Psychiatry (1998) 3.00
IQ and risk for schizophrenia: a population-based cohort study. Psychol Med (1997) 2.47
Psychiatric symptoms in cannabis users. Br J Psychiatry (1993) 1.85
Psychiatric effects of cannabis. Br J Psychiatry (2001) 1.78
Cannabis use and psychosis: a review of clinical and epidemiological evidence. Aust N Z J Psychiatry (2000) 1.36
Investigating the association between cigarette smoking and schizophrenia in a cohort study. Am J Psychiatry (2003) 1.35
Schizophrenia in users and nonusers of cannabis. A longitudinal study in Stockholm County. Acta Psychiatr Scand (1989) 1.13
Epidemiology of schizophrenia: a European perspective. Schizophr Bull (1986) 1.12
Schizophrenic subjects with no history of admission to hospital. Psychol Med (1995) 1.09
Function of male youths during military service. A follow-up study of a youth clientèle. Acta Psychiatr Scand Suppl (1980) 0.97
Cannabis and schizophrenia. Br J Addict (1989) 0.95
Non-psychotic psychiatric disorder and subsequent risk of schizophrenia. Cohort study. Br J Psychiatry (2000) 0.93
Cannabis and schizophrenia. Lancet (1988) 0.88
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 11.27
A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry (2012) 6.34
Facilitated physical activity as a treatment for depressed adults: randomised controlled trial. BMJ (2012) 5.61
Therapist-delivered Internet psychotherapy for depression in primary care: a randomised controlled trial. Lancet (2009) 3.90
Gene X environment interactions at the serotonin transporter locus. Biol Psychiatry (2008) 3.80
Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression. Systematic review. Br J Psychiatry (2002) 3.72
Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis. Int J Epidemiol (2011) 3.23
Treatment of postnatal depression in low-income mothers in primary-care clinics in Santiago, Chile: a randomised controlled trial. Lancet (2007) 3.03
A longitudinal study of premorbid IQ Score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses. Arch Gen Psychiatry (2004) 2.65
Resuscitation at birth and cognition at 8 years of age: a cohort study. Lancet (2009) 2.57
The association between cognitive ability measured at ages 18-20 and mortality during 30 years of follow-up--a prospective observational study among Swedish males born 1949-51. Int J Epidemiol (2006) 2.47
Violence against women by their intimate partner during pregnancy and postnatal depression: a prospective cohort study. Lancet (2010) 2.46
Detection of depression and anxiety in primary care: follow up study. BMJ (2002) 2.44
Diarrhoea case management in low- and middle-income countries--an unfinished agenda. Bull World Health Organ (2007) 2.40
Paternal age and risk for schizophrenia. Br J Psychiatry (2003) 2.34
A qualitative study exploring how GPs decide to prescribe antidepressants. Br J Gen Pract (2005) 2.31
Paternal age and schizophrenia: a population based cohort study. BMJ (2004) 2.27
If cannabis caused schizophrenia--how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations. Addiction (2009) 2.25
Examining interactions between risk factors for psychosis. Br J Psychiatry (2010) 2.25
Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. Am J Psychiatry (2013) 2.17
Early-onset depression, anxiety, and risk of subsequent coronary heart disease: 37-year follow-up of 49,321 young Swedish men. J Am Coll Cardiol (2010) 2.12
Fetal growth and childhood behavioral problems: results from the ALSPAC cohort. Am J Epidemiol (2006) 2.09
Violence and psychiatric morbidity in a national household population--a report from the British Household Survey. Am J Epidemiol (2006) 1.94
Obsessive-compulsive disorder: prevalence, comorbidity, impact, and help-seeking in the British National Psychiatric Morbidity Survey of 2000. Am J Psychiatry (2006) 1.93
Self-help books for depression: how can practitioners and patients make the right choice? Br J Gen Pract (2005) 1.91
Decreased kidney function of unknown cause in Nicaragua: a community-based survey. Am J Kidney Dis (2010) 1.90
The revised Helsinki Declaration: good for patients? Good for public health? Scand J Public Health (2002) 1.88
Stigma revisited, disclosure of emotional problems in primary care consultations in Wales. Soc Sci Med (2003) 1.84
Prospective study of peer victimization in childhood and psychotic symptoms in a nonclinical population at age 12 years. Arch Gen Psychiatry (2009) 1.81
The patient-doctor relationship: a synthesis of the qualitative literature on patients' perspectives. Br J Gen Pract (2009) 1.80
Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda. BMC Psychiatry (2010) 1.73
Contribution of common genetic variants to antidepressant response. Biol Psychiatry (2012) 1.73
Psychosis, victimisation and childhood disadvantage: evidence from the second British National Survey of Psychiatric Morbidity. Br J Psychiatry (2004) 1.72
Negative self-schemas and the onset of depression in women: longitudinal study. Br J Psychiatry (2005) 1.69
Parental socioeconomic status and risk of offspring autism spectrum disorders in a Swedish population-based study. J Am Acad Child Adolesc Psychiatry (2012) 1.65
IQ and non-clinical psychotic symptoms in 12-year-olds: results from the ALSPAC birth cohort. Br J Psychiatry (2008) 1.64
Alcohol consumption as a risk factor for anxiety and depression: results from the longitudinal follow-up of the National Psychiatric Morbidity Survey. Br J Psychiatry (2005) 1.63
Adolescent alcohol and tobacco use and early socioeconomic position: the ALSPAC birth cohort. Pediatrics (2011) 1.60
Clinical effectiveness of collaborative care for depression in UK primary care (CADET): cluster randomised controlled trial. BMJ (2013) 1.56
Childhood conduct disorder trajectories, prior risk factors and cannabis use at age 16: birth cohort study. Addiction (2013) 1.56
The association between early autistic traits and psychotic experiences in adolescence. Schizophr Res (2012) 1.55
Epilepsy and psychiatric comorbidity: a nationally representative population-based study. Epilepsia (2012) 1.54
Self-reported psychotic symptoms in the general population: results from the longitudinal study of the British National Psychiatric Morbidity Survey. Br J Psychiatry (2006) 1.54
Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry (2008) 1.53
Unemployment at a young age and later sickness absence, disability pension and death in native Swedes and immigrants. Eur J Public Health (2012) 1.52
Maternal depression during pregnancy and the postnatal period: risks and possible mechanisms for offspring depression at age 18 years. JAMA Psychiatry (2013) 1.52
Mental disorder in elderly suicides: a case-control study. Am J Psychiatry (2002) 1.49
Socio-economic position and common mental disorders. Longitudinal study in the general population in the UK. Br J Psychiatry (2006) 1.48
Ethnic differences in prisoners. 1: criminality and psychiatric morbidity. Br J Psychiatry (2002) 1.48
Paternal age and schizophrenia: further support for an association. Am J Psychiatry (2002) 1.46
Childhood infection and adult schizophrenia: a meta-analysis of population-based studies. Schizophr Res (2012) 1.46
The determinants of dermal exposure ranking method (DERM): a pesticide exposure assessment approach for developing countries. Ann Occup Hyg (2008) 1.44
Cost-effectiveness of cognitive-behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: economic evaluation of the CoBalT Trial. Br J Psychiatry (2013) 1.44
Risk of schizophrenia and other non-affective psychosis among individuals exposed to head injury: case control study. Schizophr Res (2006) 1.43
Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ (2013) 1.43
Marijuana use and risk of lung cancer: a 40-year cohort study. Cancer Causes Control (2013) 1.42
Self-rated health and mortality among young men: what is the relation and how may it be explained? Scand J Public Health (2002) 1.42
Adjustment latitude and attendance requirements as determinants of sickness absence or attendance. Empirical tests of the illness flexibility model. Soc Sci Med (2004) 1.40
Psychosis in the community and in prisons: a report from the British National Survey of psychiatric morbidity. Am J Psychiatry (2005) 1.39
[Fatigue and its causes--who governs the connection?]. Lakartidningen (2008) 1.38
Investigating the association between cigarette smoking and schizophrenia in a cohort study. Am J Psychiatry (2003) 1.35
Social adversity in childhood and the risk of developing psychosis: a national cohort study. Am J Psychiatry (2005) 1.33
Trends in service use and treatment for mental disorders in adults throughout Great Britain. Br J Psychiatry (2004) 1.32
Perceptions of social capital and the built environment and mental health. Soc Sci Med (2006) 1.32
Effects of stressful life events, maternal depression and 5-HTTLPR genotype on emotional symptoms in pre-adolescent children. Am J Med Genet B Neuropsychiatr Genet (2009) 1.31
Deciding who gets treatment for depression and anxiety: a study of consecutive GP attenders. Br J Gen Pract (2005) 1.30
Birth weight and psychological distress at age 45-51 years: results from the Aberdeen Children of the 1950s cohort study. Br J Psychiatry (2005) 1.30
The association between cognitive ability measured at ages 18-20 and coronary heart disease in middle age among men: a prospective study using the Swedish 1969 conscription cohort. Soc Sci Med (2007) 1.29
Self-reported illness and use of health services in a rural district of Vietnam: findings from an epidemiological field laboratory. Scand J Public Health Suppl (2003) 1.26
Adolescent self-harm and suicidal thoughts in the ALSPAC cohort: a self-report survey in England. BMC Psychiatry (2012) 1.26
Socioeconomic differences in lung cancer incidence: a systematic review and meta-analysis. Cancer Causes Control (2009) 1.24
The Aberfan disaster: 33-year follow-up of survivors. Br J Psychiatry (2003) 1.24
Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects. Am J Psychiatry (2007) 1.23
Individuals, schools, and neighborhood: a multilevel longitudinal study of variation in incidence of psychotic disorders. Arch Gen Psychiatry (2010) 1.22
Socio-economic status in childhood and later alcohol use: a systematic review. Addiction (2007) 1.21
Ethnic differences in prisoners. 2: risk factors and psychiatric service use. Br J Psychiatry (2002) 1.20
Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis. PLoS Med (2012) 1.19
Geographic variation in the prevalence of common mental disorders in Britain: a multilevel investigation. Am J Epidemiol (2003) 1.19
Cannabis, COMT and psychotic experiences. Br J Psychiatry (2011) 1.18
Alcohol use and alcohol consumption-related problems in rural Vietnam: an epidemiological survey using AUDIT. Subst Use Misuse (2008) 1.17
Patients' views of physical activity as treatment for depression: a qualitative study. Br J Gen Pract (2011) 1.16
Is socioeconomic status in early life associated with drug use? A systematic review of the evidence. Drug Alcohol Rev (2009) 1.16
Mortality and causes of death among homeless women and men in Stockholm. Scand J Public Health (2011) 1.16